Trial Profile
Drug Use Investigation for AVOLVE(BPH)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 18 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2011 New trial record